<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="pmid: 24433304 doi: 10.1186/1471-2458-14-41 : Research Article Influenza vaccines and" exact="influenza" post="antiviral drugs in Africa: are they available and do"/>
 <result pre="morbidity and mortality in Africa, particularly among high-risk groups, but" exact="influenza" post="vaccines and antiviral drugs may not be commonly available"/>
 <result pre="this study was to determine the availability and use of" exact="influenza" post="vaccines and antiviral drugs as well as to describe"/>
 <result pre="in Africa. Methods A self-administered survey was distributed among key" exact="influenza" post="experts in 40 African countries. Results Of the 40"/>
 <result pre="surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal" exact="influenza" post="vaccine, and 19/31 (65%) reported availability of antiviral drugs"/>
 <result pre="available for 4/14 (29%) countries that reported availability of seasonal" exact="influenza" post="vaccine and ranged from &amp;lt;0.5% to 2% of the"/>
 <result pre="and identifying funding are essential to encourage countries to use" exact="influenza" post="vaccine more widely. Influenza Vaccine Antiviral Drugs Policy Recommendations"/>
 <result pre="of inpatient and outpatient respiratory cases, respectively, tested positive for" exact="influenza" post="between 2006–2010 [2]. For many years, influenza epidemiology has"/>
 <result pre="tested positive for influenza between 2006–2010 [2]. For many years," exact="influenza" post="epidemiology has been described in countries with temperate climates"/>
 <result pre="Morocco [3,4] but there are now data that comprehensively describe" exact="influenza" post="viruses in tropical countries like Kenya and Zambia [5,6]."/>
 <result pre="in tropical countries like Kenya and Zambia [5,6]. In Africa," exact="influenza" post="causes severe illness and deaths in both temperate and"/>
 <result pre="and limited access to health care. For example, outbreaks of" exact="influenza" post="A(H3N2), which circulates widely across the globe, have caused"/>
 <result pre="Africa are four times more likely to die from an" exact="influenza" post="infection than their counterparts in the United States [11]."/>
 <result pre="The high prevalence of comorbidities including human immunodeficiency virus and" exact="tuberculosis" post="contribute to increased influenza-associated mortality in Africa [7]. Vaccination"/>
 <result pre="Africa [7]. Vaccination is the most effective way to prevent" exact="influenza" post="illness and antiviral drugs help treat viral infection [12]."/>
 <result pre="countries in the African Region have capacity to produce seasonal" exact="influenza" post="vaccines [13] and that only 2 of the 54"/>
 <result pre="combined receive only 1% to 4% of the global seasonal" exact="influenza" post="vaccine supply each year [15]. With growing data on"/>
 <result pre="each year [15]. With growing data on the burden of" exact="influenza" post="across the African continent, many countries are considering introducing"/>
 <result pre="are considering introducing or expanding strategies to prevent and manage" exact="influenza" post="infection. We conducted this study to gather more data"/>
 <result pre="this study to gather more data on the availability of" exact="influenza" post="vaccines and antiviral drugs in Africa as well as"/>
 <result pre="of Defense. We approached these institutions to identify key in-country" exact="influenza" post="experts in Africa who could answer the survey. In"/>
 <result pre="be public health research. The survey included 22 questions regarding" exact="influenza" post="vaccines, antiviral drugs and related policies and guidelines and"/>
 <result pre="determine a valid response via personal communication with an in-country" exact="influenza" post="expert. Results Of the 54 countries on the African"/>
 <result pre="the 31 countries surveyed, 14 (45%) reported availability of seasonal" exact="influenza" post="vaccine (Figure 1); six in the private sector only"/>
 <result pre="anyone to respond to this survey in Algeria, WHO reports" exact="influenza" post="vaccine is available there [14]. La Réunion also reported"/>
 <result pre="both the private and public sectors. Figure 1 Availability of" exact="influenza" post="vaccine and antiviral drugs in Africa. Table 1 Availability"/>
 <result pre="vaccine and antiviral drugs in Africa. Table 1 Availability of" exact="influenza" post="vaccine and antiviral drugs for the treatment of influenza"/>
 <result pre="of influenza vaccine and antiviral drugs for the treatment of" exact="influenza" post="in Africa* Country Region World Bank income level Vaccine"/>
 <result pre="available for 4/14 (29%) countries that reported availability of seasonal" exact="influenza" post="vaccine and ranged from &amp;lt;0.5% to 2% of the"/>
 <result pre="from &amp;lt;0.5% to 2% of the population. Countries that had" exact="influenza" post="vaccine available were from all regions of Africa and"/>
 <result pre="(chi-square = 0.19; p-value = 0.57). Among the 14 countries that reported having any" exact="influenza" post="vaccine, four (Côte d’Ivoire, Egypt, Mauritius, and Morocco) reported"/>
 <result pre="Africa has standing guidelines for the prevention and treatment of" exact="influenza" post="[19]but a national public policy regarding vaccination is yet"/>
 <result pre="as most important in influencing decision-makers to introduce and promote" exact="influenza" post="vaccine; evidence that illnesses and deaths can be prevented"/>
 <result pre="vaccine; evidence that illnesses and deaths can be prevented by" exact="influenza" post="vaccination and evidence that the national health system will"/>
 <result pre="31 respondent countries, 23 (74%) reported receiving and/or purchasing pandemic" exact="influenza" post="vaccine in or after 2009, and 19 (83%) of"/>
 <result pre="Mali, Senegal and South Africa) and La Réunion reported conducting" exact="influenza" post="vaccine research in the years 2012 and/or 2013. Lastly,"/>
 <result pre="Over the last few years, the Northern and Southern hemisphere" exact="influenza" post="vaccine formulations have been identical albeit the time in"/>
 <result pre="distributed is different. Several countries that do not currently have" exact="influenza" post="vaccine available are likely to consider doing so in"/>
 <result pre="underutilized vaccines [20], many of the countries in Africa without" exact="influenza" post="vaccine are low income. The Global Alliance for Vaccines"/>
 <result pre="for Vaccines and Immunisation (GAVI) is a public-private partnership that" exact="aids" post="low income countries in procuring vaccines. Currently, there are"/>
 <result pre="of these countries are in Africa [21]. Before the 2009" exact="influenza" post="A(H1N1) pandemic, most countries in Africa had inadequate data"/>
 <result pre="countries in Africa had inadequate data on the burden of" exact="influenza" post="disease and high risk groups to inform influenza public"/>
 <result pre="burden of influenza disease and high risk groups to inform" exact="influenza" post="public health policies [22]. Since then, influenza surveillance systems"/>
 <result pre="groups to inform influenza public health policies [22]. Since then," exact="influenza" post="surveillance systems have been strengthened and many countries are"/>
 <result pre="surveillance systems have been strengthened and many countries are studying" exact="influenza" post="incidence and seasonality, particularly among sub-groups [1,2]. Networks like"/>
 <result pre="[2] and AfriFlu [23] have increased the scientific dialogue among" exact="influenza" post="experts in Africa. Globally, one of the main concerns"/>
 <result pre="Africa. Globally, one of the main concerns is whether seasonal" exact="influenza" post="vaccine supply is adequate to meet the needs of"/>
 <result pre="[13,24,25]. A survey among 10 countries in Southeast Asia, where" exact="influenza" post="pandemics are likely to emerge, found seasonal influenza vaccine"/>
 <result pre="Asia, where influenza pandemics are likely to emerge, found seasonal" exact="influenza" post="vaccine sales in the private sector average &amp;lt;1000 doses"/>
 <result pre="[20]. In contrast, 5/15 (33%) of the African countries with" exact="influenza" post="vaccine reported having national guidelines for influenza vaccines. Investment"/>
 <result pre="African countries with influenza vaccine reported having national guidelines for" exact="influenza" post="vaccines. Investment in influenza research to promote evidence-based influenza"/>
 <result pre="vaccine reported having national guidelines for influenza vaccines. Investment in" exact="influenza" post="research to promote evidence-based influenza public health policies in"/>
 <result pre="for influenza vaccines. Investment in influenza research to promote evidence-based" exact="influenza" post="public health policies in Africa is essential to encouraging"/>
 <result pre="be low. As additional data emerge on the burden of" exact="influenza" post="disease in Africa, the identification of groups at risk"/>
 <result pre="in Africa, 2006–2010J Infect Dis2012206Suppl 1S14S2110.1093/infdis/jis60623169960 McAnerneyJMCohenCMoyesJBesselaarTGBuysASchoubBDBlumbergLTwenty-five years of outpatient" exact="influenza" post="surveillance in South Africa, 1984–2008J Infect Dis2012206Suppl 1S153S15810.1093/infdis/jis57523169963 BarakatAIhazmadHBenkaroumSCherkaouiIBenmamounAYoubiMEl"/>
 <result pre="in Morocco, 1996–2009PLoS One20116e2457910.1371/journal.pone.002457921931764 KatzMALeboEEmukuleGNjugunaHNAuraBCosmasLAudiAJunghaeMWaibociLWOlackBet al.Epidemiology, seasonality, and burden of" exact="influenza" post="and influenza-like illness in urban and rural Kenya, 2007–2010J"/>
 <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling studyLancet Infect Dis20121268769510.1016/S1473-3099(12)70121-422738893"/>
 <result pre="Dis20121268769510.1016/S1473-3099(12)70121-422738893 NairHBrooksWAKatzMRocaABerkleyJAMadhiSASimmermanJMGordonASatoMHowieSet al.Global burden of respiratory infections due to seasonal" exact="influenza" post="in young children: a systematic review and meta-analysisLancet20113781917193010.1016/S0140-6736(11)61051-922078723 collab:"/>
 <result pre="Dis2010511362136910.1086/65731421070141 Fact sheet on influenzahttp://www.who.int/mediacentre/factsheets/fs211/en/index.html PartridgeJKienyMPGlobal production capacity of seasonal" exact="influenza" post="vaccine in 2011Vaccine20133172873110.1016/j.vaccine.2012.10.11123149268 Back to immunization surveillance, assessment and"/>
 <result pre="2011Vaccine20133172873110.1016/j.vaccine.2012.10.11123149268 Back to immunization surveillance, assessment and monitoring datahttp://www.who.int/immunization/monitoring_surveillance/en/ PalacheASeasonal" exact="influenza" post="vaccine provision in 157 countries (2004–2009) and the potential"/>
 <result pre="of national public health policiesVaccine2011299459946610.1016/j.vaccine.2011.10.03022024174 Third annual African network for" exact="influenza" post="surveillance and epidemiology (ANISE) meetinghttps://www.team-psa.com/anise/2012/home.asp OpenEpihttp://www.openepi.com The World Bank"/>
 <result pre="in southeast Asia: 2008–2011PLoS One20127e5284210.1371/journal.pone.005284223285200 Countries eligible for supporthttp://www.gavialliance.org/support/apply/countries-eligible-for-support/ GessnerBDShindoNBriandSSeasonal" exact="influenza" post="epidemiology in sub-Saharan Africa: a systematic reviewLancet Infect Dis20111122323510.1016/S1473-3099(11)70008-121371656"/>
 <result pre="sub-Saharan Africa: a systematic reviewLancet Infect Dis20111122323510.1016/S1473-3099(11)70008-121371656 SteffenCDiopOMGessnerBDHacenMMHassarMKatzMAMillerMAPagetWJSchoubBDVernetGNdumbePMAfriflu--international conference on" exact="influenza" post="disease burden in Africa, 1–2 June 2010, Marrakech, MoroccoVaccine20112936336910.1016/j.vaccine.2010.11.02921111779"/>
 <result pre="Africa, 1–2 June 2010, Marrakech, MoroccoVaccine20112936336910.1016/j.vaccine.2010.11.02921111779 KienyMPCostaAHombachJCarrascoPPervikovYSalisburyDGrecoMGustILaForceMFranco-ParedesCet al.A global pandemic" exact="influenza" post="vaccine action planVaccine2006246367637010.1016/j.vaccine.2006.07.02117240560 collab: Members of the Western Pacific"/>
 <result pre="of the Western Pacific Region Global Influenza S, System RSeasonal" exact="influenza" post="vaccine policies, recommendations and use in the world health"/>
</results>
